Diabetes Medications for Cardiovascular (CV) Risk Reduction and Heart Failure with Reduced Ejection Fraction (HFrEF): Incorporating Prescribing in a Cardiology Practice – Pharmacy Resident Seminar October 1, 2020
October 1, 2020
12:30 PM - 1:20 PM
Please join us for our next Pharmacy Resident Seminar Presentation on Thursday, October 1, 2020, via Live Webinar, presented by PGY-1 Pharmacy Practice Resident, Caleb Rux, PharmD.
Type of Activity: A Knowledge-Based Activity Target Audience: Pharmacists
Time: Thursday, October 1, 2020, 12:30 pm - 1:20 pm
Fees: There is no charge for attending this activity
Location: Live Webinar
WebEx Meeting Information:
Meeting link: https://uichicago.webex.com/uichicago/onstage/g.php?MTID=e7e6c72743e59a64f4d810422a95219fb
Meeting number: 120 347 3788
Password: bwHRJHDY245
Or
Join by phone: +1-415-655-0001 United States Toll (Chicago)
Learning Objectives :
At the completion of this activity, the participant will be able to:
- Recognize the new data available for type II DM and how these findings impact clinical practice
- Discuss the role of SGLT-2 inhibitors for HFrEF without T2DM and how they compare to other medications with proven morbidity and mortality benefit in heart failure
- List potential ways pharmacists can influence and facilitate prescribing of T2DM medications outside of a primary care clinic
Disclosure: The speakers, planning committee members, and reviewers who contributed to this activity have no relevant financial conflicts of interest to disclose.
Date posted
Sep 5, 2020
Date updated
Sep 28, 2020
Speakers
